Krishnan Viswanadhan

About Krishnan Viswanadhan

Krishnan Viswanadhan is a chief strategy and operations at Agios Pharmaceuticals.

Form D filings name Krishnan Viswanadhan as a director at CARGO Therapeutics.

Krishnan Viswanadhan reports to the SEC as a director or officer of 2 public companies, including CARGO Therapeutics (CRGX).

Krishnan Viswanadhan first appears on SEC filings in 2023.

Experience

This experience comes from SEC filings. The years are when the filings name Krishnan Viswanadhan in the role, so the role may have started earlier or lasted longer.

Key Colleagues at Startups

The people Krishnan Viswanadhan works with at each company, as listed on that company's latest Form D.

Sources

1. SECCARGO Therapeutics, Inc. Form D, filed Mar 1, 2023
2. SECForms 3, 4 and 5 filed by Krishnan Viswanadhan (SEC filer 1999913)